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The phrase alcohol withdrawal seizures (AWS) refers to seizures that result from the withdrawal of alcohol after a period of 
chronic alcohol administration. A mechanism of AWS is postulated, namely the modified lipid-protein interaction (MLPI) 
mechanism. This hypothesis is based upon an evaluation of the mechanisms of membrane fluidity, calcium channels, y- 
aminobutyric acid (GABA) and glutamate in the molecular pathogenesis of AWS. The mechanism hypothesizes that acute 
ethanol treatment alters the neuronal membrane lipids which then perturbs protein events, such as affecting the GABAA re- 
ceptors, NMDA receptors and voltage-dependent Ca *+ channels ynergistically or in combination. Subsequent adaptations in 
these systems occur after prolonged administration of ethanol. A sudden withdrawal of ethanol then leads to hyperexcitability 
which results in AWS. 
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INTRODUCTION symptoms were reported by Victo?; (1) a state char- 
Ethanol is one of the oldest pharmacological agents. 
Although evidence of alcohol use dates to the Stone 
Age, alcohol-induced biological effects constitute the 
oldest of pharmacological puzzles’. The relationship 
between alcohol use and seizures is well known. For 
many years, alcohol was considered a toxic substance 
that precipitated seizures*. This conclusion evolved 
from observations that seizures occur in people using 
alcohol in excess. Studies indicated that epilepsy oc- 
curred in 25% of alcoholic individuals, and that about 
15% of epileptic patients were ‘abnormal drinkers’*. 
These results showed that the frequency of alcoholism 
and seizures or seizures occurring with heavy alco- 
hol drinking far exceeded that which might have been 
expected by chance alone. More recently, the phe- 
nomenon of alcohol withdrawal seizures (AWS) has 
been recognized as a relevant clinical issue. 
Alcohol withdrawal seizures are a seizure state re- 
lated not simply to the abuse of alcohol but specifi- 
cally to the cessation of drinking (withdrawal) follow- 
ing a period of chronic intoxication3. The symptoms 
of withdrawal manifest themselves after the period of 
intoxication has subsided for 6-7 hours. In addition 
to tremulousness, three major groups of withdrawal 
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acterized mainly by tremor and hallucinations, which 
peaks in intensity 24 hours after cessation of drink- 
ing; (2) convulsive seizures that occurred singly or in 
short bursts, in most cases between 7 and 48 hours 
after withdrawal, with a peak incidence at 24 hours 
(different peak times have been reported4); and (3) a 
state characterized by gross tremor and agitation, dis- 
orders of sense perception, and increased psychomo- 
tor and autonomic nervous system activity, known as 
delirium tremens. 
Alcohol withdrawal symptoms have some char- 
acteristics of generalized tonic-clonic seizures3, but 
there is no neocortical seizure focus, and the EEG 
during sober periods is normaIS. In addition, Tabakoff 
and Rothstein reported that approximately half of pa- 
tients with AWS demonstrated myoclonus or convul- 
sive seizures following photic stimulation. Although 
AWS can therefore be distinguished from epileptic 
seizures, they are more likely to occur in epileptics, 
since alcohol withdrawal lowers the seizure thresh- 
old’. 
Many hypotheses have been proposed to explain the 
mechanism(s) responsible for AWS, but these have 
not yet been proved. The conventional hypothesis has 
been that ethanol is a non-specific drug that acts by 
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perturbing neuronal membrane&‘. More recent data, 
however, have shown that ethanol specifically and 
selectively affects the function of certain membrane- 
bound proteins, and ion channels. Among the pro- 
teins are glutamate (Glu) receptor-gated ion channels 
(particularly N-methyl-D-aspartate (NMDA)) and y- 
aminobutyric acid (GABA) receptor-gated ion chan- 
nels. The acute effects include inhibition of NMDA- 
activated ion currents8, potentiation of GABAA- 
activated Cl- current9, and blockade of Ca2+ up- 
take’0*‘6 in neurons. Adaptations in these systems 
occur after prolonged administration of ethanol and 
have been reported to cause an increased number 
of NMDA receptors4* ’ ’ , reduced GABAA receptor 
functionst2. I3 and increased numbers of L-type Ca*+ 
channels14~ t5. Consequently, a withdrawal of ethanol 
then leads to hyperexcitatory states and ultimately 
causes AWS. 
This review evaluates the mechanisms of mem- 
brane fluidity, calcium channels, GABA and gluta- 
mate in the molecular pathogenesis of AWS. Based 
upon this evaluation, the modified lipid-protein inter- 
action (MLPI) mechanism is postulated. This mech- 
anism hypothesizes that acute ethanol treatment al- 
ters the neuronal membrane lipids which then per- 
turbs protein events. This perturbation then affects 
GABAA receptors, NMDA receptors and voltage- 
*+ dependent Ca channels synergistically or in combi- 
nation. Subsequent adaptations in these systems occur 
to counter balance the offset of these protein receptor 
systems after prolon,ged administration of ethanol. A 
sudden withdrawal of ethanol then disturbs these sys- 
tems again, leading to hyperexcitatory and resulting 
in AWS. 
In this review, the definition for lipid-protein inter- 
action is to refer to an association between lipid and 
protein which when disrupted changes the function of 
the protein. There are various possibilities for lipid in- 
teracting with protein to affect protein function. (1) 
Thickness of the lipid bilayers alters as the lipid com- 
position of the host membrane changes, which leads 
to the modification of protein function. Modification 
of the thickness of the lipid bilayer has been dis- 
cussed by Johannson ef al *‘, Moutitsen and Bloomt8 
and Sperotto and Mouritsent9. (2) Alteration of the 
membrane lipid composition changes the ‘fluidity’ of 
the membrane. 
EFFECTS OF ETHANOL ON MEMBRANE 
FLUIDITY 
Membrane physical properties 
Mammalian cell membranes consist of a lipid bilayer 
containing a variety of proteins. The lipids are quite 
diverse, including phospholipids, galactolipids, and 
neutral lipids*‘. These lipids are not randomly dis- 
tributed in the bilayers; certain lipids are localized 
predominantly in the outer leaflet of the bilayer (e.g. 
gangliosides) whilst others are mainly in the inner 
leaflet (e.g. phosphatidylserine)20. 
The main physical properties studied in alcohol re- 
search are lipid order and viscosity. Order is the mea- 
sure of packing of the lipids or, more qualitatively, 
the volume occupied by each lipid molecule. Viscos- 
ity is the resistance to the solvent drag or a mea- 
sure of the freedom of lateral movement of the lipid 
molecules. The frequently used term ‘fluidity’ does 
not have a precise definition but is usually taken to 
include both order and viscosity*‘. Other membrane 
characteristics of potential importance are membrane 
surface charge and lipid-protein interactions, but lit- 
tle is known about the effects of ethanol on these 
properties. 
Ethanol-induced disorder 
The most frequent methods used to estimate mem- 
brane fluidity include electron paramagnetic reso- 
nance (EPR), fluorescence polarization and nuclear 
magnetic resonance (NMR). Both EPR and fluores- 
cence polarization techniques are similar but some- 
times give qualitatively different results, since differ- 
ent probes measure different regions of the membrane 
that have distinct physical properties and responses to 
ethanol. Ethanol, and other anaesthetic agents allow 
exogenous probes (spin labels or fluorescence dyes) 
to move more rapidly or with greater amplitude than 
in their absence**. 
In 1977, Chin and Goldstein23 demonstrated that 
brain membranes were disordered by in vitro expo- 
sure to concentrations of ethanol that can be attained 
in vivo (10-20 mM). These investigators used EPR 
probes inserted into synaptic membranes to study 
the effects of ethanol. During the next few years, 
a number of studies24 using EPR and fluorescence 
probes demonstrated that ethanol concentrations in 
the range of 10-100 mM can disorder brain mem- 
branes. However, the effect of ethanol was smaller 
than those caused by altering body temperature a 
few degrees, and questions arose immediately. Some 
issues of concern included whether the changes in 
membrane properties were functionally important and 
whether the differences in alcohol sensitivity in vivo 
were reflected by differences in membrane sensitiv- 
ity in vitro. To address this question, attempts were 
made to correlate the membrane fluidity with some 
measure of ethanol action in vitro, as an indication of 
whether small changes were important. Membranes 
from mice with genetic differences in alcohol sensi- 
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tivity and membranes from ethanol-tolerant mice (re- 
sulting from chronic consumption of ethanol) were 
tested. Indeed, sensitivity to the membrane fluidity in 
the presence of ethanol did correlate well with ethanol 
sensitivity in viva 23*25*26. However, the decreased 
ethanol sensitivity observed in viva during early de- 
velopment and the increased sensitivity that occurred 
during ageing were not reflected by the changes in 
membrane sensitivity to ethano127. This implied that 
some, but not all, alterations in ethanol sensitivity 
in vivo could be correlated with differences in mem- 
brane properties. 
The fact that the genetic differences in alcohol sen- 
sitivity have only been detected at the membrane sur- 
face3’ raises the question of where in the membrane 
is the most pronounced (and presumably most impor- 
tant) action of ethanol. Data from both EPR and flu- 
orescence probes showed that the fluidizing action of 
ethanol was most pronounced in the membrane core 
(lower methylene groups of the acyl chains), leading 
to the conclusion that the action of ethanol becomes 
stronger toward the interior of the bilayc?O. This re- 
sult does not appear to be consistent with the fact that 
ethanol is not very lipid-soluble, and therefore the 
highest concentration will be at the membrane sur- 
face. However, more recent data from NMR studies 
supported the alternative hypothesis that the fluidizing 
action of ethanol was most pronounced at the mem- 
brane surface, and that ethanol was located near the 
membrane surface with the hydroxyl group interact- 
ing with the polar headgroup of the phospholipids and 
with the ethyl group embedded in the membrane3’. 
Thus, ethanol may have two distinct actions on the 
membrane and the EPR and fluorescence probe ex- 
periments measure an average of these two actions2’. 
NMR may be particularly useful in studying these 
two sites of ethanol action because NMR does not 
require the use of an exogenous probe, but measures 
resonances from the lipids themselves32*33. This re- 
sult also serves as an example that different methods 
of measuring membrane fluidity may lead to different 
interpretations regarding the actions of ethanol. 
Recently, Iqbal et al 49 showed that ethanol in- 
hibited [1251]calmodulin (Cah4) binding to synaptic 
plasma membranes from rat brain and decreased 1,6- 
depheny l- 1,3,5hexatriene (DiPH) fluorescence polar- 
ization (i.e. increased membrane disorder) in the con- 
centration range of 25-300 mM. This inhibition was 
correlated in a concentration-dependent manner with 
the increased membrane fluidity. In this concentration 
range, the inhibition of [ ‘251]CaM binding was 17% 
at 25 mM, 45% at 100 mM and 68% at 300 mM. The 
decreased DiPH fluorescence polarization was 0.0022 
at 25 mM and 0.0182 at 300 mM. These are in good 
agreement with those reported in earlier studies using 
similar DiPH fluorescence polarization26*29 or EPR 
spectrometry 25,28. that showed a correlation between 
ethanol and membrane fluidity. 
Adaptation and tolerance in membrane 
One might expect the adaptation of the membrane 
after chronic treatment with ethanol would result in 
the ‘too-fluid’ membrane pulling itself together and 
adjusting its properties to compensate for the contin- 
uous presence of ethanol (adaptation). Indeed, there 
are many examples of resistance to the fluidizing 
effect after chronic administration of ethanol23 and 
of decreasing membrane fluidity in the absence of 
ethano128*29. However, the effect is not universal; it 
depends on the tissue, on the method of examin- 
ing the membranes, and perhaps on the conditions 
of ethanol administration. For example, the order pa- 
rameter of mouse synaptosomal plasma membranes 
from ethanol-treated mice is higher than that of con- 
trols when the spin label is 1Zdeoxylstearic acid but 
not when it is 5-deoxylstearic acid”*28. 
Whether or not the membranes of ethanol-treated 
animals are more ordered than normal, they are usu- 
ally resistant to ethanol-induced disordering in vitro 
(tolerance). In a study by Goldstein34, tolerance de- 
veloped in mice over a few days of ethanol expo- 
sure, and it decayed rapidly within 30 hours of with- 
drawal. The magnitude of the tolerance was about 
twofold or in other words, the tolerant mice can ex- 
hibit functional balance at a brain concentration of 
ethanol nearly twice that of controls34. 
Rottenberg and co-workers35*36 demonstrated a de- 
creased solubility of ethanol in membranes from 
ethanol-treated rats, and they suggested that the mem- 
brane tolerance was simply the result of lower con- 
centrations of ethanol within the membranes of the 
ethanol-treated animals. This might indeed explain 
the tolerance due to the reduced solubility of ethanol 
when the membranes are rigid. 
Chemical basis for increased order 
The experiments described above demonstrated that 
membrane tolerance and increased order after chronic 
ethanol administration are frequent but not univer- 
sal findings. To discover the causes of membrane 
stiffening after chronic ethanol treatment, investiga- 
tions on the chemical changes in membranes have 
been performed. The search for altered lipids focuses 
on cholesterol and saturated acyl chains of phospho- 
lipids because increased amounts of these compo- 
nents are expected to stiffen membranes and to ren- 
der them relatively resistant to ethanol-induced disor- 
der. Indeed, in some situations, the membrane choles- 
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teroYphospholipid ratio does increase during ethanol 
treatment, for example in mouse synaptosomal mem- 
branes after treatment of mice with ethanol by diet3’. 
Cholesterol does not always increase after chronic 
ethanol treatment. In some mice studies, when tol- 
erance and physical dependence was developed, 
membranes showed corresponding cholesterol in- 
creases28. But in other similar experiments, it was 
found that there was no change in the choles- 
teroYphospholipid ratio of the brain synaptosomal 
plasma membranes38. Others have even found a de- 
creased cholesterol/phospholipid ratio in synaptoso- 
ma1 membranes from ethanol-treated animals2’. 
Membranes from ethanol-treated animals often 
showed an apparently analogous increased saturation 
of acyl chains 38*3g, but this again was not a univer- 
sal finding. Sometimes the membrane fatty acids be- 
came more unsaturated, contrary to prediction40*4’. 
Several investigators, including Smith er ULNA, com- 
mented on the possible confounding effects of dietary 
and nutritional factors on these different responses to 
ethanol. Studies showed that, in some cases, ethanol 
enhanced the depletion of polyunsaturated fatty acids 
in the brain when the diet was deficient in these fatty 
acids43, whereas others found no changes among the 
polyunsaturated fatty acids44*45. 
Thus, there is currently no simple model to demon- 
strate the role between saturated and polyunsaturated 
fatty acids which is explained by or correlated with 
the compensatory reorganization of neuronal mem- 
branes that have adapted to ethanol. In addition, adap- 
tations may proceed by various mechanisms simul- 
taneously22. If the primary objective of the adapta- 
tion is to counteract disorder, the organism may use 
cholesterol, fatty acid chains, and other mechanisms 
simultaneously, and one or another may be detectable 
to the investigator after different periods of ethanol 
exposure22. 
Recently, a pathway for alcohol metabolism which 
yields an unusual phospholipid phosphatidylethanol 
(PEt) product had been reported46, Omodeo-Sale et 
a14’ reported that at higher PEt concentrations (5 
10% of the total phospholipids), PEt induced an in- 
crease of fluidity of artificial and natural bilayers and 
that it was able to confer membrane tolerance to the 
fluidizing effects of ethanol. However, at physiologi- 
cal PEt concentrations (l-2% of total phospholipids), 
there seems to be little effect on membrane fluidity or 
on the tolerance to ethanol. On the other hand, one 
cannot exclude that in some membrane microenvi- 
ronments these effects might be amplified by a local 
increase of PEt concentration. 
It is speculated that by hydrophobic head group 
of PEt might perturb the membrane architecture by 
disrupting the hydrogen or ionic bond lattice extend- 
ing over the surface of the membrane4’. For ex- 
ample, Omodeo-Sale4’ found that incorporation of 
small amounts of PEt (2% of the total phospho- 
lipids) resulted in significant changes in the activ- 
ity of Na+/K+ ATPase and S-nucleotidase, reduc- 
ing the Na+/K+ ATPase activation and enhancing 
S-nucleotidase activity. These authors suggested the 
PEt-induced reduction of Na+/K+ ATPase activity 
could be related either to the resistance to ethanol- 
induced fluidization acquired by membranes enriched 
with PEt, or to a more specific influence of PEt on the 
catalytic site of the enzyme, or on some lipid-lipid or 
lipid-protein interactions. The PEt-induced increased 
5’-nucleotidase activity could be caused by a direct 
interaction of the polar head group of PEt with the 
catalytic portion of the enzyme at the membrane sur- 
face where it was located48. 
Summary of ethanol-membrane interactions 
Although the adaptive lipid modifications brought 
about as a result of chronic ethanol treatment remains 
an attractive hypothesis, testing has revealed many 
inconsistencies. One may find a large body of obser- 
vations that fit the general outlines of the idea, but 
there are many exceptions. Perhaps these will pro- 
vide clues to the actual mechanism of responses to 
ethanol. 
Even though there is a general consensus about the 
effects of ethanol on membrane fluidity, the key ques- 
tion is whether any of these effects are of physiolog- 
ical importance. Investigators have pointed out that 
the observed changes may be too small (1% change 
in the order parameter) to alter membrane function. 
Nevertheless, the membrane fluidity hypothesis has 
yet to be disproved. Alternative hypotheses can also 
explain the correlation between ethanol and mem- 
brane fluidity changes. For example, ethanol could act 
on specific protein sites which are within the mem- 
brane; thus, ethanol action would be proportional to 
the membrane concentration, which, in turn, is pro- 
portional to the change in membrane fluidity2’. Alter- 
natively, the action of ethanol may be at another site 
(e.g. membrane calcium binding). Moreover, it can 
be due to the unusual phospholipid(s) produced by 
alcohol metabolism (e.g. PEt) that exert their effects 
on the physicochemical properties of the membrane 
or perhaps on the proteins themselves. 
The interaction of ethanol with neuronal mem- 
branes, including lipid and protein components, 
causes significant changes in membrane function. 
Furthermore, it has not been proven that a sin- 
gle effect, such as an alteration in membrane flu- 
idity, is solely responsible for all functional alter- 
ations. The studies of cellular calcium, NMDA re- 
ceptors and GABA receptors (discussed below), sug- 
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gests AWS may be due to combination effects on cal- 
cium channels, NMDA receptors and GABA recep- 
tors, which results from the alteration(s) in neuronal 
membrane lipids during chronic ethanol treatment; it 
is likely that these effects cause AWS as the ethanol 
is withdrawn. Thus, the proposed mechanism is that 
acute ethanol treatment alters the neuronal membrane 
lipids; this alteration then perturbs protein events that 
in turn affect the GABAA receptors, NMDA receptors 
and voltage-dependent Ca channels synergistically or 
in combination. Subsequent adaptations in these sys- 
tems occur after prolonged administration of ethanol, 
and a sudden withdrawal of ethanol then causes hy- 
perexcitation which results in AWS. 
EFFECTS OF ETHANOL ON CELL CALCIUM 
Ethanol is known to alter both intracellular Ca2+ con- 
centrations and Ca*+ movement across cell mem- 
branes5’. In addition to passage through ion selective 
channels, controlled by transmembrane potential and 
ion concentration gradients, Ca2+ is actively moved 
via membrane exchange with sodium and by Ca’+- 
activated ATPases. It is the influx of Ca2+ which can 
lead to seizure activity and cell death. Ion channels 
permeable to Ca2+ include both voltage-gated and 
ligand-gated processes. Voltage-operated Ca2+ chan- 
nels have been divided into subtypes, according to 
their voltage dependence, inactivation characteristics, 
and responses to drugs5’. 
Electrophysiologic evidences* suggested that at 
least four distinct types of voltage-operated Ca2+ 
channels are present on neurons. They have differ- 
ent pharmacological and electrical properties. Chan- 
nels with long opening periods which need consid- 
erable depolarization for activation, but inactivate 
slowly, have been designed L-type. Channels that 
open transiently (T-type) require low levels of de- 
polarization for activation but inactivate very rapidly. 
Those with an intermediate opening period (N-type) 
require considerable levels of depolarization for acti- 
vation but inactivate rapidly. The Ca2+ channel types 
are distributed regionally: those on the terminals be- 
ing largely the N-type, whereas those on cell bodies 
and dendrites appear to be of the L- and T-type&‘. 
Only the L-type channel is susceptible to inhibition 
by clinically available Ca2+ channel antagonists. The 
most potent group of Ca2+ channel antagonist are 
the 1,4-dihydropyridines (DHPs); the L-type channel 
is sometimes described as the DHP-sensitive chan- 
nel. However, DHPs may not be as selective for the 
L-type channel in normal mammalian neurons as for 
those in cultured neurons. For example, in hypothala- 
mic cells, DHPs are found to affect channels that pos- 
sess the voltage dependence and inactivation charac- 
teristics of L-type channels and those with character- 
istics of the T-type channels52. In addition, DHPs can 
have either antagonistic effects or agonistic effects on 
the channels3. Therefore, one cannot simply assume 
that the functional consequences of a DHP antago- 
nist will always reflect inhibition of depolarization- 
induced Ca2+ entry. Acute ethanol administration and 
chronic ethanol intake have been reported to alter 
intracellular Ca2+ concentrations, Ca2+ uptake, and 
Ca2+ current9O. 
Acute effects of ethanol on cell calcium 
Acute effects on intracellular calcium concentrations. 
Harris54 found that ethanol (50 mM-1.6 M) decreased 
ATP-dependent Ca2+ uptake by lysed synaptosomal 
tissue. Similar results were obtained after acute ad- 
ministration of ethanol (4 g/kg) in vivo. Chronic treat- 
ment with ethanol conferred tolerance to its effect 
on ATP-dependent Ca2+ uptake, and decreased ATP- 
dependent uptake in the absence of ethano154s55. Shah 
and Pant56 showed that ethanol (30-500 mM) induced 
Ca2+ release from microsomes, prepared from puri- 
fied synaptosomes. Consequently, intracellular Ca2+ 
concentration was increased by the acute effect of 
ethanol. 
The concentrations of ethanol that affected intra- 
cellular Ca2+ levels were considerably higher than 
those achieved during the behavioural actions of so- 
cial ethanol ingestion. This suggests that alterations 
in intracellular Ca2+ concentration might not play a 
significant role in the mechanism(s) of the acute ac- 
tions of ethanol. However, in the majority of the stud- 
ies described above, measurements were made using 
synaptosomes. Synaptosomal Ca2+ concentrations do 
not necessarily reflect those in other regions of the 
neuron. It is becoming increasingly apparent that lo- 
cal variations in Ca2+ distribution occur in different 
areas of the cell, and these may play an important 
role in the control of excitability50. The possibility 
remains, therefore, that local changes in the intra- 
cellular Ca2+ concentration may be important in the 
mechanism of action of ethanol. 
Acute effects of ethanol on calcium uptake. Evidence 
on the effects of ethanol on Ca2+ uptake into neu- 
rons has been conflicting. For example, Blaustein et 
a151 found no change in synaptosomal uptake on ad- 
dition of 100 mM ethanol, while Harris and Hood13 
reported that SO-800 mM ethanol decreased K+- 
stimulated Ca2+ uptake in brain synaptosomes, but 
the changes were small until very high concentrations 
were reached. In contrast, Friedman et a15* found that 
ethanol increased Ca2+ influx into mouse whole-brain 
synaptosomes at 80 mM. A similar effect was seen 
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45 minutes after administration of an acute ethanol 
dose (4.5 g/kg) in viva. On the other hand, Stokes 
and Harri~‘~ found that ethanol inhibited Ca2+ up- 
take into synaptosomes, with greater action on the 
cerebellum. and striatum than on cerebral cortex and 
brain and stem. 
The fast component of Ca2+ uptake into synapto- 
somes was blocked by concentrations that were asso- 
ciated with the in viva actions of ethanol, but the slow 
component of uptake was not affected strongly in this 
range50. Leslie er af@ demonstrated an inhibitory ac- 
tion on the slow component at 25 mM. Effects were 
found on the fast component of Ca2+ uptake over 
longer incubation periods in concentrations out of the 
relevant range 64 As a result, the effects of ethanol . 
on Ca2+ uptake are inconsistent. Hence, the acute 
ethanol effects on Ca2+ uptake are still questionable. 
Acute effects of ethanol on calcium currents. There 
is considerable evidence for a selective action of 
ethanol on Ca2+ currents. Pozos and Oakes6’ found 
that ethanol (1 l-l 10 mM) decreased the duration of 
somatic action potentials, which was interpreted as 
a decrease in Ca2+ conductance. At concentrations 
lower than 11 mM, ethanol increased spike duration, 
an effect suggested to be due to increased Ca2+ con- 
ductance and to be related to the hyperexcitability 
caused by low doses of ethanol in viva. This gives 
rise to the question of what causes a dependency of 
Ca2+ current on ethanol concentration. 
Ethanol at 5-20 mM, as shown by Carlen et af6’, 
can increase the postsynaptic Ca2+-mediated K+ 
conductance that underlies after-hyperpolarization in 
CA1 cells of the isolated rat hippocampus. These au- 
thors suggested that the changes were due to either an 
increased sensitivity to Ca2+ or an increase in intra- 
cellular Ca*+ concentration. Increased sensitivity to 
Ca2+ was also suggested as an important mechanism 
of action of ethanol by Lynch and Littleton62, who 
studied the effect of chronic ethanol on neurotransmit- 
ter release. In contrast to the above results, Siggins et 
af63, also using isolated rat hippocampal slices, found 
no evidence of such potentiation. Ca2+-activated K+ 
currents were either unchanged or decreased by the 
acute administration of ethanol (1 l-150 mM). The 
authgrs suggested that the differences between their 
results and those of Carlen et ~1~’ may be due to the 
method of ethanol administration, because Siggins er 
a163 used bath perfusion whereas the earlier study 
added ethanol by microdrop. Benson et al@, who 
measured the effects of ethanol (50-100 mM) in a 
voltage-clamp study on hippocampal pyramidal cells, 
also failed to find an effect on the Ca2+-dependent 
K+ current. 
Thus the results are conflicting, as with membrane 
fluidity, but again the differences may be due to 
the tissues used, the method of examining the mem- 
branes, and perhaps the conditions of ethanol admin- 
istration. Unfortunately, this complicates the determi- 
nation of the effects of ethanol further. 
Effects of chronic ethanol treatment on cell 
calcium 
Daniel1 and Harri@ reported that in the absence of 
ethanol, intracellular Ca2+ concentrations were not 
significantly altered after 7 days on a liquid diet, but 
the mean value was altered after ethanol treatment. 
In addition, Friedman et uf5* found that the action 
of ethanol was considerably reduced in tissues from 
mice treated with a liquid ethanol diet for 10 days 
(17 g/kg/day), due to tolerance. In the absence of 
ethanol added to the medium, synaptosomes from an- 
imals receiving the chronic ethanol diet showed de- 
creased Ca2+ accumulation in both depolarizing and 
non-depolarizing conditions. 
Cultured cells of neural origin (i.e. PC12 cells) 
showed decreased Ca2+ uptake when 50 mM ethanol 
was added acutely to the medium66. When the cells 
were grown in 200 mM ethanol for 6 days, this ac- 
tion of ethanol was unaltered, but Ca2+ uptake in the 
absence of ethanol was increased by 75%. Greenberg 
et uf61 showed that this increase could be blocked by 
the dihydropyridine nifedipine, at nanomolar concen- 
trations, suggesting that it occurred through voltage- 
sensitive channels. Skattebol and Rabi#*, however, 
found an increase in the effects of ethanol on voltage- 
dependent Ca2+ uptake when PC12 cells were grown 
in 150 mM ethanol for 4 days. The difference in these 
studies was suggested by the latter authors to be due 
to the use of difference subclones of cells. These au- 
thors also made the point that the difference between 
the effects of chronic administration of ethanol in viva 
and its action on PC12 cells, was likely due to the 
wide variety of effects of ethanol in viva, in contrast 
to its direct action on cultured cells6*. 
Effects of ethanol on dihydropyridine-sensitive 
calcium channels 
Changes in DHP binding. Greenberg and Cooper7’, 
Harris ef uf” and Rius ef uf72 found that the acute 
addition of ethanol in vitro had little effect on DHP 
binding in brain homogenates, except at extremely 
high concentrations. It was concluded that a direct 
action on DHP binding was unlikely to be involved 
in the actions of ethanol (acute treatment). However, 
this may not be the case in terms of the effects of 
the membrane potential on DHP binding. DHP Ca2’ 
channel antagonists bind preferentially to the inacti- 
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vated form of the channel complex73. Rius et al’* 
showed that a single dose (3 g/kg, i.p.) of ethanol, 
caused an increase in DHP binding of short duration, 
followed by an increase in affinity with maximum 
affinity 8 hours after ethanol administration. 
Chronic ethanol treatment increased the number 
of DHP binding sites in the cerebral cortex’7*‘8, in 
whole brain74, and in peripheral excitable tissues75. 
This effect has been reported for a variety of ethanol- 
treatment schedules: inhalation of ethanol by rats (IO, 
rising to 20 g/kg/day) for 7 days76*77, i.p. injection 
of ethanol in rats at 2 g/kg, once daily, for 10 daysIs, 
and administration of ethanol in the drinking fluid to 
mice (1 l-14 g/kg/day) for 12 weeks”. The inhalation 
and drinking-fluid methods of administration caused 
tolerance to ethanol and a mild withdrawal syndrome. 
The i.p. injection schedule caused tolerance, but no 
withdrawal signs. The increase in the number of DHP 
binding sites was variable, depending on ethanol con- 
centration and the duration exposure, but could be 
well in excess of 100%. 
An increase in the number of DHP sites was also 
found by Wu et a178 who demonstrated a temporal 
correlation between the increase in binding sites and 
ethanol tolerance. In addition, an increase in DHP 
binding-site number has also been found in PC12 
cells of a cultured neural cell line grown in 200 mu 
of ethanol for 6 days66. The increase in DHP binding 
sites was prevented by the protein synthesis inhibitor 
cycloheximide (at the mRNA translation stage) and 
by lomofungin and anisomycin (which inhibit mRNA 
synthesis), suggesting that it was a consequence of 
synthesis of new channel proteins7g. As mentioned 
before, it is unlikely that ethanol acts directly on 
DHP binding sites, so the question becomes what 
causes the increase of DHP binding sites after chronic 
ethanol treatment? In addition, a change in the num- 
ber of DHP binding sites is of interest only if the in- 
creased binding sites represent functional entities. The 
in vitro effects of the DHP Ca*+ agonist, Bay K-8644, 
on neurotransmitter release and phosphotidyl inosi- 
to1 turnover were increased in cortical tissue from 
rats treated chronically with ethanol by inhalation for 
7 days18. These authors suggested that the increase in 
DHP binding sites appeared to reflect an increase in 
voltage-sensitive Ca*+ channels, which implies that 
the increase in DHP binding sites does represent func- 
tional entities. 
Recently, Huang and McArdle” also showed with 
their electrophysiological study, that increased Ca*+ 
current from hippocampal neurons of ethanol-tolerant 
mice was due to an increase in the number of func- 
tioning Ca *+ channels and not to changes in their 
gating or permeability properties. The authors also 
suggested that hyperexcitability was due to the in- 
creased number of Ca*+ channels. When ethanol is 
withdrawn, the increased number of Ca*+ channels 
in hippocampal CA1 neurons gives rise to the hyper- 
excitability in ethanol withdrawal rats8’. 
Effects of dihydropyridines in ethanol withdrawal. DHP 
Ca*+ channel antagonists decrease the hyperexcitabil- 
ity associated with withdrawal from chronic ethanol 
administration. They protect against both the tremor 
and convulsive behaviour that occur in mild with- 
drawa176, and the spontaneous and audiogenic con- 
vulsions that follow chronic treatment with higher 
doses of ethano18*. DHP Ca*+ channel antagonists 
can also prevent adaptations to chronic ethanol treat- 
ment, if they are given chronically during the ethanol 
intake76. Such administration prevents the devel- 
opment of alcohol tolerance in animal models’7~78 
by preventing the increase in the number of DHP- 
sensitive Ca*+ channels caused by the chronic ethanol 
treatment’7*74. 
DHP Ca*+ channel antagonists have been shown to 
decrease the number of available DHP binding sites 
in peripheral tissues83. Two groups have investigated 
the effects of repeatedly administering DHPs together 
with ethano178*84. In one series of experiments, an 
increase in available DHP binding sites in the brain 
was shown when ethanol alone is given, but this ef- 
feet was prevented when a DHP Ca*+ channel antag- 
onist was co-administereds5. Both groups found that 
concurrent administration of the DHP significantly re- 
duced the development of alcohol tolerance78*84. In 
subsequent experiments, administration of DHP Ca2+ 
channel antagonist with ethanol was shown to prevent 
AWS even when the DHP was withdrawn 24 hours 
before the removal of ethanol”. 
DHP Ca*+ channel antagonists protect against the 
effects of ethanol withdrawal. The questions that 
need to be asked are: whether the effects are pro- 
duced by action at neuronal Ca*+ channels, and 
whether the action is selective for ethanol withdrawal. 
The sterospecificity of the isomers of the PN 200- 
110 Ca*+ channel antagonist in protecting against 
AWS was the same as that on Ca*+ channel con- 
ductance76. This stereospecificity, and the correlation 
with the dose required to displace a radiolabelled 
DHP from binding sites in the CNS, suggested that 
the effect was mediated by neuronal voltage-sensitive 
Ca*+ channels, rather than a non-specific action76. 
DHP Ca*+ channel antagonists were found to have 
weak anticonvulsant actions against some other forms 
of convulsions, such as pentylenetetrazol seizures, 
and no action against others, such as NMDA or elec- 
troshock seizures86 . The evidence therefore suggested 
that the Ca*+ channel antagonists were selective for 
ethanol withdrawal signs, rather than that they pos- 
sessed general anticonvulsant actions86. 
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Littleton” and Dolin and LittleI suggested that the 
increase in DHP binding sites after chronic adminis- 
tration of ethanol was the result of an adaptive up- 
regulation mechanism in the synthesis of Ca2+ chan- 
nels. They put forward a theory to explain the effects 
of DHP Ca*+ antagonists on ethanol tolerance and 
withdrawal. The evidence (according to these authors) 
for this theory are: (1) acute ethanol decreases Ca*+ 
influx (conflicting data showing increased intracellu- 
lar Ca*+ concentrations has been reported, 3.1. l), not 
necessarily through DHP-sensitive Ca*+ channels; (2) 
the number of DHP-sensitive Ca*+ channels in the 
CNS is increased after chronic ethanol treatment; 
and (3) concurrent chronic administration of DHP 
Ca*+ channel antagonists prevents the up-regulation 
of DHP binding, the development of ethanol tolerance 
and the behavioural and electrophysiological manifes- 
tations of the ethanol withdrawal syndrome. 
Summary of ethanol-Ca*+ interactions 
Both acute and chronic effects of ethanol on cellular 
Ca*+ have not shown any general consensus. How- 
ever, there is strong evidence that chronic ethanol 
administration results in an increase in the number 
of DHP binding sites, which reflects the increase in 
DHP Ca*+ channels. In addition, it is suggested that 
ethanol physical dependence is associated with an 
adaptive up-regulation of DHP-sensitive Ca*+ chan- 
nels on excitable cells. On removal of ethanol from a 
dependent animal, the increase in the number of Ca*+ 
channels on central neurons causes hyperexcitability 
expressed as AWS. Treatment with DHP Ca*+ chan- 
nel antagonists can decrease the hyperexcitability, and 
prevent AWS. This agrees with the MLPI mechanism 
that acute ethanol treatment alters the neuronal mem- 
brane lipids, which then perturbs voltage-dependent 
Ca*+ channels. Subsequent adaptations in this sys- 
tem (up-regulation of DHP sensitive Ca*+ channels) 
occur after chronic administration of ethanol, and a 
sudden withdrawal of ethanol then causes hyperexci- 
tation which results in AWS. 
EFFECTS OF ETHANOL ON GABA 
RECEPTORS 
GABA is a major inhibitory neurotransmitter in the 
CNS. It acts at two types of receptor: the GABAA 
site, at which it increases chloride (Cl-) conductance 
and the GABAn site, coupled to adenyl cyclase which 
increases Ca*+ conductance. The GABAA receptor is 
part of a protein complex that also bears the benzodi- 
azepine (BZD) receptor sites that bind picrotoxin and 
the barbiturates, and the Cl- ionophore*‘. There ap- 
pears to be at least two binding sites for GABA within 
this complex, each with different affinities. Most stud- 
ies on the actions of ethanol on GABA transmission 
have involved the GABAA receptor ionophore. 
The hypothesis that reduced inhibitory GABA-ergic 
action in the CNS might be responsible for hyperex- 
citability during ethanol withdrawal is based on two 
observationsg6. (1) Many clinical and animal stud- 
ies showed that drugs known to augment GABA- 
ergic function can suppress AWS. For example, val- 
proate and vigabatrin, which increase the availabil- 
ity of endogenous GABA, and agents like muscimol, 
barbiturates, and BZD, which interact more directly 
with GABA receptors, all suppress AWS. Conversely, 
drugs that blocked either GABA synthesis or GABA 
receptors can induce seizures that resemble AWSg7. 
(2) Ethanol directly stimulates GABA-ergic neuro- 
transmission. Although ethanol does not directly ac- 
tivate a specific receptor, some electrophysiological 
and biochemical results suggested that ethanol can 
either increase the efficiency of endogenous or ex- 
ogenously applied GABAg7-lo0 or directly activate 
GABA-ergic receptor mechanisms via an allosteric 
interactiongg* loo. 
Acute effects of ethanol on 
GABAlbenzodiazepine (BZD) receptor complex 
Acute administration of ethanol both in vivo and 
in vitro at relevant concentrations does not appear 
to alter GABA or BZD. Tickugo, however, showed 
that acute ethanol treatment increased the density 
of GABA receptors. Tolerance to this effect oc- 
curred after prolonged ethanol intake. Davis and 
Tickug’ showed that ethanol acted at the picrotoxin- 
sensitive site within the GABACI- ionophore to 
increase BDZ binding. This occurred at concen- 
trations between 20 and 100 mM ethanol; above 
100 mM ethanol there was less effect. An increase 
in the number and affinity of GABA receptors is 
expected to increase normal GABA transmission, 
but it is uncertain what effect the potentiation of 
BZD binding will have. Thyagarajan and Tickug3 
showed that at high concentrations (100-500 mM) 
ethanol non-competitively decreased the binding of r- 
butylbicyclophosphorothionate (TBPS), a ligand that 
binds to the picrotoxin site. Liljequist et alg4 also 
showed this effect of ethanol at 20-100 mM. Sanna 
et afg5 further demonstrated that this effect occurred 
after in vivo administration of low doses (0.5-l g/kg) 
of ethanol and involved a decrease in the apparent 
affinity of the binding sites. 
Electrophysiological studies. Various electrophysio- 
logical studies have shown potentiation of the actions 
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Table 1: In vitro GABA transmission (acute effects of ethanol). 
Tissue (ref.) Response study [EtOH](mM) Effects of Ethanol 
Frog spinal cord Primary afferent 33-100 Increase in depolarization 
(98) 
Cultured mouse 
spinal cord cells 
(9% 
Hippocampal slices 
CA1 pyrimidal cells 
(58) 
Hippocampal slices 
(100) 
Hippocampal slices 
CA1 and CA3 cells 
(60) 
Cultured chick spinal 
cord cells 
(102) 
Hippocampal slices 
CA1 pyrimidal cells 
(101) 
Superior colliculus 
Substantia nigra 
depolarization 
Apply GABA 
Apply GABA 
Inhibitory currents 
Apply GABA 
Inhibitory currents 
Apply GABA 
Apply GABA 
Apply 3H-GABA 
Apply 3H-GABA 
20-80 
5-20 
100 
IO-200 
22-88 
10-350 
20-50 
70 
20-100 
20-100 
No change or small 
potentiation 
No potentiation 
Small potentiation 
No effect 
No change 
Mostly decrease 
Potentiation 
Potentiation 
Decrease release 
No change or increase release 
(103) Apply 3H-GABA loo-500 Inhibit release 
of GABA in vitro with 33-100 mM of ethanolto’ 
as shown in Table 1. Gru01’~~ found that cultured 
mouse spinal cord neurons showed either no change 
or a very small increase in the responses to applied 
GABA when 2O80 mM of ethanol was added. Carlen 
et a16’ using 5-20 mM ethanol concentrations, found 
no evidence of potentiation of GABA-ergic effects on 
CA1 pyramidal cells in isolated hippocampal slices, 
but some potentiation was seen with 100 mM ethanol. 
Gage and Robertson lo3 found no detectable effects of 
ethanol (lo-200 mM) on inhibitory synaptic currents 
in an isolated rat hippocampal slice. 
No evidence of potentiation of GABA was seen 
by Siggins et a163, who studied rat hippocampal 
slices using intracellular recording from CA1 pyra- 
midal cells after application of GABA. Increases 
were not seen in the amplitude of the hyperpolar- 
izing responses to GABA. In the majority of cells, 
ethanol (22-80 mM) either failed to alter or slightly 
reduced the GABA effect. Inhibitory postsynaptic po- 
tentials produced by stimulation of the stratum radia- 
turn, thought to be mediated by GABA, were con- 
sistently reduced by ethanol, over the 10-350 mM 
concentration range. Takada et al ‘04 however, found 
that ethanol increased the inhibition by GABA of 
population spikes in CA1 cells (from hippocampal 
slices), when ethanol concentrations of 70 mM and 
higher were used. A voltage clamp study of chick 
spinal-cord neurons found that ethanol (20-50 mM) 
increased the actions of GABAto5. In contrast, Gage 
and Robertson103 found that bath-applied ethanol, at 
concentrations between 10 and 200 mM, had no ef- 
fect on spontaneous GABA-mediated inhibitory post- 
synaptic currents, recorded by voltage clamp from 
pyramidal cells in hippocampal slices. Peris et allM 
noted that the effects of ethanol exposure in vim 
on 3H-GABA release differed depending on the re- 
gion studied. Low concentrations (20-100 mM) de- 
creased GABA release in the superior colliculus (SC), 
whereas the same concentrations of ethanol had no ef- 
fect or increased release in the substantia nigra (SN). 
Only higher concentrations (lOO-500 mM) of ethanol 
inhibited release from SN. 
The differences between these studies may have 
been due to the concentrations used, potentiation be- 
ing somewhat more consistent with the higher ethanol 
concentrations, but this is clearly not the entire expla- 
nation for the disparate results. For instance, in one of 
the studies cited above, it was observed that the effect 
of ethanol was critically dependent on the duration 
of its applicationro5. Short (10 second pulse) appli- 
cations of ethanol, applied locally from a multibarrel 
pipette, caused consistent potentiation of the actions 
of applied GABA, while longer ethanol application 
(30 second pulses) did not have this effect. The au- 
thors suggested that the interaction between ethanol 
and GABA might involve multiple competing pro- 
cesses. This type of interaction may also account for 
some of the variability in the effects of ethanol on 
GABA inhibition. 
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Tissue (ref.) 
Cerebral cortex 
Table 2: In viw GABA transmission (acute effects of ethanol). 
Response study [EtOH](g/kg) Effects of ethanol 
Action potential frequency Iontophoresis Potentiation of effects of GABA 
ww 
Cerebelliu Purkinje GABA-mediated inhibition Iontophoresis Decrease in inhibition 
cells 1.5 (i.v.) Decrease in inhibition 
(107) Action potential frequency Iontophoresis Decrease effects of GABA 
Hoppocampus Action potential frequency 1.5 No consistent change in effects 
(105) of GABA 
Hippocampus Recurrent inhibition 2.0 Potentiation of inhibition 
WW 
Even when studies in vivu are included, the picture 
is no clearer (Table 2). Nestoros’07 demonstrated se- 
lective potent&ion of GABA-ergic actions by ion- 
tophoretically applied ethanol. Mantillas et al to8, 
however, found no consistent change in responses of 
hippocampal neurons to GABA after systemic admin- 
istration of 1.5 g/kg ethanol. Wiesner et al to9 noted 
that i.p. injection of ethanol (2 g/kg) increased recur- 
rent inhibition in the dentate gyrus, measured indi- 
rectly by pair-pulse stimulation. This may have been 
due to enhancement of GABA-mediated inhibition or 
by decreased pair-pulse potentiation, increased after 
hyperpolarization or decreased recovery of excitabil- 
ity. Harris and Sinclair”“, on the other hand, found 
that ethanol decreased GABA-mediated inhibition in 
cerebellar Purkinje cells. 
There is a confounding consideration in these stud- 
ies because the recordings were made under the in- 
fluence of halothane anaesthesia. It is very difficult 
to interpret results obtained during the application of 
ethanol against a background of the actions of another 
general anaesthetic agent. The drug used to produce 
the anaesthesia may itself have already affected the 
actions of GABA, either directly or indirectly, and in- 
teractions may occur between the actions of ethanol 
and the other pharmacological agent. 
Ethanol-enhanced increases in the action of GABA 
or GABA agonists on chloride (Cl-) flux (mea- 
sured biochemically) have been found consistently. 
‘licku and co-workerslOO* ’ 1 ’ using cultured spinal- 
cord neurons, found that ethanol increased the action 
of GABA over a 5-100 mM concentration range. Al- 
lan and Hanisg8 showed that IO-45 mM ethanol, in- 
creased the action of muscimol on Cl- uptake into 
membrane vesicles. Suzdak et ul”* using synap- 
toneurosomes, found increased GABA agonist action 
at an ethanol concentration of 10 mM. Ethanol was 
also found to have a direct action on synaptoneu- 
rosomes, increasing Cl- uptake in the absence of 
GABA agonists. The EDso for this was between 25 
and 35 mM, while concentrations higher than about 
60 mM were less effective”*. 
The fact that the effects of ethanol on both GABA- 
induced Cl- flux and GABA binding occurred over 
the concentration range which also produces be- 
havioural effects suggests that these actions may be 
of importance in the mechanism of acute ethanol ac- 
tion. An increase in binding need not be necessary 
for potentiation of GABA actions. In vitro studies on 
Cl- flux showed that potentiation occurred at con- 
centrations produced by lower doses of ethanol than 
those needed to affect binding. This gives rise to the 
question, what causes the altered Cl- flux if the effect 
is not through binding and why does it only occur at 
low ethanol concentrations. 
The low concentrations that produce behavioural 
excitation (5-20 mM) have either no effect on GABA 
or qualitatively similar actions to the higher concen- 
trations (50-100 mM). When the amount of ethanol is 
increased above the latter concentrations, the effects 
on GABA transmission either decrease or do not in- 
crease further. This is perhaps due to other actions of 
ethanol on the cell membrane that come into play at 
higher ethanol concentrations (toxic levels), prevent- 
ing normal functioning of the GABA ionophore. 
GABA release and reuptake. Effects of ethanol on 
GABA synthesis, release, and re-uptake are the sub- 
ject of a number of earlier studies which yielded in- 
conclusive resultsg7. Ethanol (150-500 mM) inhibited 
K+-stimulated release of GABA from cortical brain 
slices and synaptosomes ‘I3 but a lower concentration 
(60 mM) was not effective’ 14. An acute injection of 
ethanol did not change GABA content or GABA ac- 
cumulation in the rat brain’ 15. In vitro ethanol (up 
to 400 mM) did not alter synaptosomal high affinity 
GABA uptake’16. Taken together, these observations 
suggest that non-toxic concentrations of ethanol has 
little effect on presynaptic regulation of GABA-ergic 
transmission. 
Ethanol tolerance and dependence on GABA 
BZD receptor complex 
Chronic ethanol administration has been found to 
decrease low-affinity GABA binding in a rodent 
brain87*90 Rat studies by Tickugo, showed that treat- 
ment with 1 l-17 g/kg/day ethanol, for 21 days, which 
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was sufficient to cause AWS, decreased the affinity 
of the low-affinity GABA binding site. This change 
was not seen after shorter treatment duration, which 
did not result in behavioural withdrawal, and was 
found only over the period during which audiogenic 
seizure activity was seen. Rastogi et al ’ I7 studied the 
effects of chronic ethanol treatment on GABA stim- 
ulation of [35S]-TBPS binding, a liquid that binds at 
the picrotoxin site, and GABA stimulation of [3H]- 
flunitrazepam binding, and found that these interac- 
tions were unchanged. These allosteric effects were 
considered to reflect the coupling between GABA re- 
ceptors and other sites on the GABA-Cl- ionophore 
complex’ 17. 
Hunt and Dalton* ‘* did not find changes in GABA 
binding while Harris et al ‘I9 found GABA binding to 
be increased after chronic ethanol administration. The 
difference in results may be methodological. The lat- 
ter study was carried out on brain tissue from minia- 
ture swine, and there may be species differences. 
Binding at the BZD receptor is either decreased’20q t*’ 
or unchanged’*** ‘23 after chronic ethanol treatment. 
Deitrich et aI*’ reported that GABA agonists and 
BZD agonists potentiated the effect of ethanol (poten- 
tiate GABA-ergic responses), whereas BZD antago- 
nists blocked the potentiating effect of BZD agonists 
but did not affect the depressant effects of ethanol. 
These results suggested that ethanol can potentiate 
GABA-ergic effects but that it does not do so via a 
BZD-like action on the receptor-channel complex*‘. 
Allan and Harris’* found that chronic ethanol treat- 
ment abolished the potentiation of muscimol-related 
Cl- uptake into microsacs seen with acute ethanol 
(10-45 mM) (prepared from mouse cerebellar tis- 
sue). Morrow et al 124 demonstrated tolerance action 
of ethanol on Cl- flux into synapneurosomes after 
chronic treatment with ethanol in viva inhalation for 
14 days. In the latter study, potentiation by ethanol of 
GABA-agonist stimulated Cl- uptake was lost com- 
pletely after chronic treatment. Takada et al ‘04 stud- 
ied the effects of ethanol by extracellular recordings 
on hippocampal slices prepared from rats 4 days af- 
ter cessation of chronic ethanol treatment (2 g/kg, 
twice daily for 30 days). These authors104 found that 
inhibition by exogenous GABA resulted population 
spikes in the CA1 area of the hippocampal occurred 
to the same extent after chronic treatment as in con- 
trol slices. The potentiation of this effect by ethanol at 
concentrations above 70 mM, seen in control prepa- 
rations, was lost after chronic treatment. Whittington 
and Little125 described the patterns of hyperexcitabil- 
ity that were seen in extracellular recording from iso- 
lated hippocampal slices, prepared immediately on 
withdrawal from chronic ethanol treatment. Their re- 
sults suggested that several different mechanisms may 
underlie the withdrawal hyperexcitability, including a 
decrease in GABA-mediated inhibition produced by 
down regulation of GABA after chronic ethanol ad- 
ministration. In addition, chronic ethanol treatment 
has been reported to decrease the behavioural effects 
of GABA agonists, suggesting either down-regulation 
of GABA receptors or alterations in coupling’26*127. 
However, there are other studies that do not show 
behavioural adaptations to ethanol. 
As mentioned before, GABA agonists, such as 
muscimol, BZD and THIP, and agents that increase 
GABA concentrations such as sodium valproate and 
vigabatrin, have been found to decrease AWS128* I*‘. 
BZD agonists have been suggested to be the drugs of 
choice in treating withdrawal in alcoholics, but they 
do not prevent the dependence, they merely decrease 
AWS130. In addition, BZDs are anticonvulsants effec- 
tive against a wide variety of in vitro seizure models 
(other than those purely due to blockage of GABA 
transmission), including NMDA’?‘, digoxin13*, pilo- 
carpine133, and nicotine-induced seizures134. There- 
fore direct relevance to specific mechanism of AWS 
is still uncertain. 
Chronic ethanol treatment has been reported to de- 
crease the number and affinity of GABA receptor 
sites. Can these changes be responsible for the AWS? 
Careful and detailed studies by Tickugo showed that 
there was a temporal correlation between binding 
changes and the appearance of withdrawal behaviour. 
Decreases in GABA binding can be responsible for 
tolerance to those actions of ethanol that are pro- 
duced by potentiation of GABA transmission. How- 
ever Harris et ~1”’ found no change in the number 
of GABA receptors after chronic ethanol intake. As 
mentioned before, the functional importance of the 
high affinity GABA site is uncertain, as it will be sat- 
urated at the normal GABA concentrations achieved 
in the synaptic cleft. 
Summary of ethanol-GABA interactions 
The hypothesis that ethanol potentiates GABA-ergic 
transmission is attractive and is quite consistent with 
many behavioural and neurochemical results. How- 
ever, there are many electrophysiological observa- 
tions that do not support this hypothesis. Attempt- 
ing to resolve the apparent differences between the 
effects of ethanol on GABA-ergic responses in var- 
ious preparations and laboratories may be prema- 
ture, because currently available studies do not clearly 
show which experimental variables are important and 
which are not*O. However, several hypotheses can 
be proposed that may prove important in integrat- 
ing these findings. First, several studies indicate that 
only some components of the GABA response are 
affected. This suggests that with certain methods of 
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ethanol application, differences will not be observed 
because the transient component cannot be easily de- 
tected. Second, it is possible that the effect of ethanol 
is region specific within the brain. 
Another difference may relate to recent findings 
that there are multiple forms of the subunits for the re- 
cepto?** 135, which underlie the heterogeneity among 
the GABAA receptor subtypes. In addition, it is possi- 
ble that these subunits may have different sensitivities 
to the effects of ethanol, whilst some subunit(s) might 
not even be affected by ethanol. For example, Waf- 
ford and Whiting136 find that the y2L subunit of the 
GABAA receptor is minimally present in hippocam- 
pal membranes. This then raises the possibility that 
the y2L subunit may play an important role in AWS, 
whereas other subunits present in hippocampal mem- 
branes are not sensitive to ethanol. Further investiga- 
tions on the homogeneous y2L subunit will support 
this hypothesis. Unfortunately, no such investigation 
has been reported so far. 
In general, brain regions in which GABA modu- 
lation by ethanol is typically not observed, such as 
the hippocampus, may have a receptor variant that is 
not sensitive to ethanol, whereas a receptor subtype 
that is affected will be expected in regions such as 
the cortex and possibly cerebellum, in which mod- 
ulation is observed. This type of heterogeneity may 
exist even among cells from the same brain area. For 
example, using cultured spinal cord neurons, Study 
and Barker’37 found that, although all of the cells 
tested respond to GABA, the GABA response was 
potentiated by diazepam in 82% of the cells, by pen- 
tobarbital in 85% of the cells, and by both drugs in 
only 53% of the cells. 
In summary, both behavioural and neurochemical 
results support the MLPI mechanism which acute ad- 
ministration of ethanol potentiates GABA-ergic trans- 
mission. After chronic administration of ethanol, sub- 
sequent adaptation by down regulating the GABA- 
ergic transmission occurs. A sudden withdrawal of 
ethanol then leads to hyperexcitation, and results in 
AWS. 
EFFECTS OF ETHANOL ON GLUTAMATE 
RECEPTORS 
Glutamate (Glu) is one of the primary neurotrans- 
mitters mediating excitatory neurotransmission in the 
CNS by means of ligand-gated cation channels’. Ma- 
jor excitatory neuronal systems in the brain, including 
the cortical pyramidal cells, primary sensory affer- 
ems, cerebellar granule cells, and the ascending exci- 
tatory pathways, use Glu or related excitatory amino 
acids as their neurotransmitter138. 
Glutamate receptors are widely distributed 
throughout the CNS. There are four subtypes 
of Glu receptors, designed as NMDA, kainate, 
cr-amino-3-hydroxy-5-methyl-isoxazole-4-propionic 
acid (AMPA), and quisqualate’38. These can be clas- 
sified into two major families on the basis of their 
mechanisms of transduction: (1) ionotropic recep- 
tors, which are coupled to a cation ion channel, and 
(2) metabotropic receptors, which are coupled to 
inositol 1,4,5triphosphate turnover mediated by G 
protein. The Glu-gated ionophores are the receptor 
family that show the best correlation with the diverse 
ethanol effects on the CNS. These ion channels can 
be further subclassified, according to their respec- 
tive high affinity ligands, into NMDA, kainate, and 
AMPA subtypes. 
The NMDA receptor is activated by Glu or NMDA, 
and channel opening mediates an increase in perme- 
ability to Na+, K+, and Ca*+. The activity of the 
NMDA receptor complex is subjected to modula- 
tion by a number of agents, including Mg2+, which 
causes a direct voltage-dependent blockage of the ion 
channel, Zn2+, which decreases channel function in a 
voltage-independent manner at a site peripheral to the 
channel, and glycine (Gly), which modulates NMDA 
receptor activity allosterically through a strychnine- 
insensitive Gly recognition site and has been sug- 
gested as a co-agonist 139 Within the channel there is .
also a site that binds phencyclidine and MK-801 to 
produce a non-competitive inhibition140. Additional 
modulation is produced by a site that mediates the 
NMDA-enhancing effects of the polyamines14’. The 
NMDA receptors also play a major role in synap- 
tic plasticity (e.g. long-term potentiation) and neuro- 
toxicity (e.g. seizures and ischemic damage to neu- 
rons)142. It is the influx of Ca2+ which is believed 
to contribute to the involvement of the NMDA re- 
ceptor to synaptic plasticity and development. How- 
ever, when the receptor is excessively stimulated, the 
influx of Ca2+ can lead to seizure activity and cell 
death14’. There is evidence that alcohol affects glu- 
tamatergic transmission in three ways: by interfering 
with fast excitatory neurotransmission, by promoting 
excitatoxicity (persistent or excessive activation of 
Glu receptors), and by impairing neurodevelopment’. 
Neurochemical effects of ethanol on 
glutamatergic transmission 
During acute exposure, ethanol produces diverse ef- 
fects on neurotransmission. Ethanol inhibits the re- 
lease of serotonin, dopamine, norepinephrine, Glu, 
Asp, and GABA 143. These effects are suggested to 
be indirectly mediated through the NMDA recep- 
tor’. Ethanol acts like an NMDA antagonist, inhibit- 
ing NMDA-stimulated Ca influxlti. Gulya et al 145 
Alcohol withdrawal seizures 267 
found that 100 mM of ethanol inhibited the non- 
equilibrium binding of [3H]MK-801, which is an in- 
dex of NMDA receptor-channel opening. This inhi- 
bition can be reversed in a time- and concentration- 
dependent manner by the addition of Gly. In addi- 
tion, Gonzales and Woodward found that the in- 
hibition was also brain regional-dependent. In sub- 
sequent studies, Woodward et a114’, using rat stri- 
atal slices, showed that the ability of Gly to an- 
tagonize the ethanol-induced inhibition of NMDA- 
stimulated endogenous dopamine release was appar- 
ent at 25 mM, but not at ethanol concentrations of 
50 mM and higher. This result suggested that even 
within brain regions, ethanol might possess multiple 
actions that cause a change in NMDA-stimulated pro- 
cesses. 
Acute ethanol administration has no effect on Glu 
release, uptake, or tissue concentration in the fore- 
brain. However, it causes a significant decrease in 
Asp and Glu concentrations in midbrain and brain- 
stem, and decreases Glu tissue concentration (but not 
release) in the hippocampust4*, in agreement with the 
notion of regional brain dependence. Iorio et a114’ 
found that tolerance to some of these effects do not 
appear to develop, as there is no change in the ability 
of ethanol to inhibit the NMDA response in cerebel- 
lar granule cells after chronic exposure of neurons to 
ethanol. 
When experimental animals were subjected to 
chronic ethanol administration, Michaelis et al Iso 
found that the number of Glu receptor binding sites 
increased in synaptosomal membranes. Gulya et al4 
and Grant et a115’ found that chronic ingestion of 
ethanol (7% ethanol for 7 days) produced increases 
in MK-801 binding sites by approximately 40-50%, 
a marker for NMDA receptors, in cerebral cortex, 
shiatum, thalamus, and hippocampus. and that these 
increases lasted between 10 and 24 hours. 
The increase in the number of MK-801 binding 
sites is probably a compensatory mechanism (up- 
regulation of NMDA receptors) for overcoming the 
ethanol-mediated inhibition of NMDA/Glu neuro- 
transmission. This inhibitory effect of ethanol has 
been observed in cultured cerebellar granule cells’52 
and hippocampal cells ’ ’ , as well as in slices of rat 
cortex’52 and striatum 153. Thus, it is not surprising 
that NMDA receptors in these brain regions are up- 
regulated after chronic ethanol ingestion. However, it 
remains to be determined whether the increase in the 
number of MK-801 binding sites reflects an increase 
in function of NMDA receptors. 
Several investigators have shown that both con- 
trol and ethanol-treated cells are protected against 
neurotoxicity if the cells are exposed to Glu in the 
presence of high concentrations of the NMDA recep- 
tor antagonists CGS-1975514t (a competitive antag- 
onist of Glu), 5,7-dichlorokynurenate*4* (a Gly-site 
antagonist) or ADCI15’ (an ion channel antagonist). 
Snell et al ‘54 reported that chronic ethanol exposure 
did not affect the apparent affinities and densities of 
NMDA-specific [3H]Glu, [3H]CGS-19755, [3H]Gly 
or [3H]MK-801 binding sites. This result suggests 
that the inhibition of function is not mediated by di- 
rect competition of ethanol with ligand binding at any 
of these sites, which further suggests a specific modu- 
lation of ethanol on the NMDA channel ionophore in- 
stead. McGowan etaf I48 found that intracellular Ca*+ 
concentration is significantly enhanced after chronic 
in vitro exposure to ethanol. The enhancement is con- 
sistent with an increased number of NMDA receptors, 
through which Ca*+ can enter neurons. The authors 
further reported that during chronic dependent states, 
Glu release is decreased; conversely, uptake and tis- 
sue concentration of Glu are increased. However, dur- 
ing the ethanol withdrawal state, Glu synaptic release, 
uptake, and tissue concentration are increased. Re- 
gional variations were observed, by Keller et a1155, 
with regard to these effects and the degree of effects. 
In addition, Hoffman170 reports that acute (2 hour, 
200 PM) or chronic (3 days, 50 PM) exposure 
of cerebellar granule cells to ganglioside GMt pro- 
tects control and ethanol-treated cells against Glu 
neurotoxicity. However, while the acute ganglioside 
GM1 treatment does not interfere with initial re- 
sponse to Glu (increase in intracellular Ca*+), this 
response is ‘down-regulated’ after chronic ganglio- 
side GM1 treatment. Furthermore, chronic ganglio- 
side GM1 treatment during ethanol exposure has the 
potential to prevent the ethanol-induced up-regulation 
of NMDA receptors that underlies AWS and the in- 
creased susceptibility to excitotoxicity, which further 
prevent withdrawal-induced neuronal damage”‘. 
Electrophysiological effects of ethanol on 
glutamatergic transmission 
A predominant electrophysiological effect of ethanol 
is to reduce excitatory glutamatergic synaptic trans- 
mission156. Lovinger ef al ’ found that ethanol in- 
hibits the electrical current generated by NMDA re- 
ceptor activation, and that this inhibition is concentra- 
tion dependent. Concentrations of ethanol associated 
with intoxication in vivo correlate with those caus- 
ing inhibition of NMDA currents. Simson et a115’ 
reported that ethanol produces a dose-dependent in- 
hibition of the ability of NMDA to activate medial 
septal neurons in vivo. In addition, ethanol also po- 
tently inhibits NMDA-evoked neuronal activity in a 
current-dependent manner in the inferior colliculus 
and hippocampus. Clearly, the ability of ethanol to in- 
hibit NMDA-evoked neuronal activity varies region- 
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ally. For example, Simson et al ‘58 found that ethanol 
fails to inhibit NMDA-evoked activity in the lateral 
septum. The complex regulatory responses of sev- 
eral NMDA subunits may explain the variation in 
the sensitivity of different neurons to ethanol as with 
GABA subunits to ethanol, or may be due to region- 
specific differences in inhibition. Molecular cloning 
of Glu receptor subunits and the functional expres- 
sion of different combinations of Glu receptor sub- 
units indicated that the NMDARl and NMDAR2C 
channels are slightly less sensitive to ethanol inhi- 
bition than the other heterometric channels’5g. Sim- 
ilarly, Lovinger160 discovered that some forms of 
non-NMDA ionotropic Glu receptors have relatively 
high ethanol sensitivity, which appears to differ from 
that of endogenous AMPA or kainate receptors. In 
addition, Ishii et ~1’~’ reported that the NMDARI 
mRNA is expressed throughout diverse brain regions, 
whereas NMDAR2 mRNA is distinctly distributed in 
different brain regions. 
Pathophysiological studies 
Lustig et al 16* demonstrated that acute ethanol ad- 
ministration protects against Glu-induced excitotoxic 
degeneration of cortical neurons. Acutely, neuropro- 
tection by ethanol is accompanied by a decrease 
in the NMDA-evoked elevation of free intracellu- 
lar Ca*+. Because of its effect in attenuating glu- 
tamatergic transmission, acute ethanol administra- 
tion protects against NMDA-induced convulsions. 
Also, MK-801 and ethanol have synergistic anticon- 
vulsant effects163. However, chronic attenuation of 
Glu neurotransmission by ethanol results in com- 
pensatory up-regulation of NMDA receptors. As a 
consequence, ethanol withdrawal should be expected 
to be associated with increased excitatory neuro- 
transmission. Consistent with this deduction, a non- 
selective Glu antagonist, glutamic acid diethyl ester, 
attenuates the seizures associated with withdrawal of 
ethanol after chronic ingestionl”. Several investiga- 
tors’54* ‘63 found that NMDA exacerbates, while MK- 
801 and other NMDA receptor antagonists decrease, 
the occurrence and severity of AWS. During with- 
drawal, Valverius ef al ‘65 reported that mice have 
56-7096 more MK-801 binding sites. Ethanol-naive 
mice prone to withdrawal seizures have been found to 
have more MK-801 binding sites in the hippocampus. 
Chronic exposure to ethanol can sensitize neurons 
to the excitotoxic effect of NMDA receptor activa- 
tion because of the up-regulation of the NMDA re- 
ceptors166* 16’. Of 11 studies addressing potential al- 
terations in NMDA-receptor-mediated neurotransmis- 
sion with ethanol dependence, 10 studies of rodents 
indicated that long-term exposure to ethanol causes 
up-regulation of NMDA receptor density or its Ca*+- 
mediated events’49.151.154.165-167 
Excitatory amino acids, including Glu and Asp, 
exert trophic influences on neuronal differentiation 
and are thus important for neurodevelopment’68. 
They regulate the formation of neuronal circuitry and 
synaptic plasticity. Activation of NMDA receptors 
enhances synaptogenesis in the hippocampus’6g. Glu 
exposure accelerates the maturation of synaptic pro- 
files. Exposure to excitatory amino-acid receptor an- 
tagonists may disrupt the maturational processes me- 
diated by excitatory amino acids and interfere with 
normal neurodevelopment. 
Summary of ethanol-glutamate interactions 
Overall, the results indicate a significant role for in- 
creased NMDA receptor function in both AWS and in 
the neuronal damage that is associated with chronic 
ethanol exposure and withdrawal. The increase in 
NMDA receptor function observed in ethanol-treated 
animals and cells may represent an adaptive response 
to the initial inhibition of NMDA receptor function 
by ethanol. The presence of ethanol in the cells is 
expected to protect the cells from the consequences 
of NMDA receptor up-regulation, which will appear 
after chronic treatment of ethanol, and result in AWS 
after ethanol is eliminated or removed. This further 
supports the MLPI mechanism in which acute ethanol 
treatment alters neuronal membrane lipids, resulting 
in an inhibition of glutamatergic transmission. Sub- 
sequent adaptation of this system (by up-regulation 
of NMDA receptors) occur after chronic treatment of 
ethanol. A sudden withdrawal of ethanol then causes 
hyperexcitation which leads to AWS. 
As for neuronal damage, it is likely that the re- 
peated up-regulation of NMDA receptors is a key fac- 
tor. However, the question of how acute ethanol ex- 
posure results in decreased NMDA-stimulated Ca*+ 
influx which leads to an adaptive response still re- 
mains unanswered. Various reports support the con- 
tention that ethanol withdrawal hyperexcitability can 
be treated with drugs that are antagonists at the 
NMDA receptor. In addition, chronic ganglioside 
GM1 treatment during ethanol exposure has the po- 
tential to prevent the ethanol-induced up-regulation 
of NMDA receptors and thus AWS, which further 
prevents withdrawal-induced neuronal damage. 
CONCLUSION 
Ethanol produces alterations in neuronal membrane 
function, ranging from the activities of membrane- 
bound enzymes to the activities of ion channels and 
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neurotransmitter receptors. However, the extent to 
which these alterations affect membrane properties 
remains incompletely elucidated. More recently, it 
has been noted that certain membrane-bound pro- 
teins, such as GABAA receptors and NMDA recep- 
tors, are affected by low concentrations of ethanol 
(less than 50 mM), whereas other membrane-bound 
proteins, such as voltage-dependent Ca*+ channels, 
are affected only at higher concentrations of ethanol. 
These differential responses to low and high concen- 
trations of ethanol do not necessarily preclude mem- 
brane fluidization as the underlying mechanism. The 
bilayers of biomembranes consist of heterogeneous 
types of phospholipids, and different phospholipids 
have different sensitivities to the fluidizing effects 
of ethanol. Therefore, it is possible that the respon- 
siveness of a membrane-bound protein to ethanol de- 
pends upon the type of lipids present in the membrane 
microenvironment. 
Studies have shown that membrane fluidity is un- 
likely to affect the activity of certain membrane- 
bound proteins directly, in particular those that are 
subjected to complex biochemical regulation, such as 
receptor gated ion channels. Rather, the alteration of 
membrane fluidity may perturb regulatory events that 
in turn affect the activity of these membrane-bound 
proteins or the membrane surface potential. These ef- 
fects can then affect the GABAA receptors, NMDA 
receptors and/or voltage-dependent Ca*+ channels 
synergistically or in any combination. The effects in- 
clude an increase of GABAA function, and a decrease 
of both NMDA action and voltage-dependent Ca*+ 
channel function, which result in different changes 
depending on brain region and/or cellular ethanol sen- 
sitivity. Subsequent adaptation of these cells, results 
in increased NMDA receptors and voltage-dependent 
Ca channels (up-regulation), and decreased GABAA 
function (down- regulation). A sudden withdrawal of 
ethanol then causes hyperexcitation which results in 
AWS. This hypothesis (MLPI mechanism) explains 
why there is not a strong consensus for a single mech- 
anism among the enormous number of studies that 
have been performed; none the less, these studies do 
show that each mechanism plays an important role in 
AWS. 
Nevertheless, this hypothesis, as well as all the 
studies that have been presented in this review, do 
not explain how membrane fluidity actually causes 
changes in GABA and NMDA receptors, and cal- 
cium channels. As previously noted. ethanol has the 
potential to disrupt the surface membrane potential. 
This then raises questions: Can the alteration of sur- 
face membrane potential affect ion channels (i.e. ion 
flux)? How significant will changes of ion flux af- 
fect the activity of these membrane-bound proteins? 
Is the alteration ion channel specific? To answer these 
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questions, further experimental investigations are re- 
quired, such as studies on surface membrane po- 
tentials with voltage-dependent Ca*+ flux current, 
GABAA-activated Cl- current and ion current acti- 
vated by NMDA. 
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